Analysis of the Oral Hypoglycemic Agent, Glibenclamide, in a Health Food

Yakugaku Zasshi - Japan
doi 10.1248/yakushi.123.1049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Evaluation of Patients’ Responses to Oral Hypoglycemic Agents at a University Health Centre

Journal of Pharmaceutical Research International
2019English

Serum Glibenclamide in Diabetic Patients, and Influence of Food on the Kinetics and Effects of Glibenclamide

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1980English

Perception of Foreign Compounds in Food as Health Threat Agent

Zywnosc. Nauka. Technologia. Jakosc/Food. Science Technology. Quality
IndustrialFood ScienceManufacturing Engineering
2010English

Glibenclamide as a Promising Agent for Prevention and Treatment of Cerebral Edema

Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko
MedicineNeurology
2017English

Oral Hypoglycemic Agents: Do the Ends Justify the Means?

Maternal Health, Neonatology and Perinatology
2015English

Mucuna Gum Microspheres for Oral Delivery of Glibenclamide: In Vitro Evaluation

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2007English

The Choice of Oral Hypoglycemic Agents: The Current View of the Problem

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2013English

Uses of Spatial Analysis in Oral Health Research

Journal of Dental and Maxillofacial Surgery
2018English

A 1-Year Safety Study of Dulaglutide in Japanese Patients With Type 2 Diabetes on a Single Oral Hypoglycemic Agent: An Open-Label, Nonrandomized, Phase 3 Trial

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy